BCR-ABL suppresses C/EBPα expression through inhibitory action of hnRNP E2
- 20 December 2001
- journal article
- Published by Springer Nature in Nature Genetics
- Vol. 30 (1) , 48-58
- https://doi.org/10.1038/ng791
Abstract
The arrest of differentiation is a feature of both chronic myelogenous leukemia cells in myeloid blast crisis and myeloid precursors that ectopically express the p210BCR-ABL oncoprotein; however, its underlying mechanisms remain poorly understood. Here we show that expression of BCR-ABL in myeloid precursor cells leads to transcriptional suppression of the granulocyte colony-stimulating factor receptor G-CSF-R (encoded by CSF3R), possibly through down-modulation of C/EBPalpha-the principal regulator of granulocytic differentiation. Expression of C/EBPalpha protein is barely detectable in primary marrow cells taken from individuals affected with chronic myeloid leukemia in blast crisis. In contrast, CEBPA RNA is clearly present. Ectopic expression of C/EBPalpha induces granulocytic differentiation of myeloid precursor cells expressing BCR-ABL. Expression of C/EBPalpha is suppressed at the translational level by interaction of the poly(rC)-binding protein hnRNP E2 with CEBPA mRNA, and ectopic expression of hnRNP E2 in myeloid precursor cells down-regulates both C/EBPalpha and G-CSF-R and leads to rapid cell death on treatment with G-CSF (encoded by CSF3). Our results indicate that BCR-ABL regulates the expression of C/EBPalpha by inducing hnRNP E2-which inhibits the translation of CEBPA mRNA.Keywords
This publication has 44 references indexed in Scilit:
- Optimized RNA Targets of Two Closely Related Triple KH Domain Proteins, Heterogeneous Nuclear Ribonucleoprotein K and αCP-2KL, Suggest Distinct Modes of RNA RecognitionJournal of Biological Chemistry, 2001
- Lipoxygenase mRNA Silencing in Erythroid DifferentiationCell, 2001
- Diversification of haematopoietic stem cells to specific lineagesNature Reviews Genetics, 2000
- Chronic Myeloid LeukemiaNew England Journal of Medicine, 1999
- Inhibition of CCAAT/Enhancer-binding Protein α and β Translation by Upstream Open Reading FramesJournal of Biological Chemistry, 1998
- BCR – ABL activates pathways mediating cytokine independence and protection against apoptosis in murine hematopoietic cells in a dose-dependent mannerOncogene, 1998
- Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl.The Journal of Experimental Medicine, 1996
- A 30-kDa alternative translation product of the CCAAT/enhancer binding protein alpha message: transcriptional activator lacking antimitotic activity.Proceedings of the National Academy of Sciences, 1993
- CCAAT/enhancer-binding protein mRNA is translated into multiple proteins with different transcription activation potentials.Proceedings of the National Academy of Sciences, 1993
- Chronic myelogenous leukemia in blast crisisThe American Journal of Medicine, 1987